News



Dicot and Uppsala University Holding enters in a venture for the development of the libiguins


Uppsala, Sweden, 13 May 2015


Uppsala University Holding (UUAB), the Uppsala university holding company for development and commercialization of research at Uppsala University and Dicot today entered into a venture for the development of the libiguins.

The venture increases Dicot's ability substantially to develop the libiguins as a prescription remedy for treatment of sexual dysfunction, says Dicotyledon CEO Jarl Wikberg.